Docetaxel Injection Recalled Due to Particulate Matter in Stopper
Sagent Pharmaceuticals is recalling Docetaxel Injection due to particulate matter from the vial stopper. Lot F1040001 was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall. Per the severity rubric, FDA Class I recalls warrant a minimum severity score of 4 (Severe), regardless of whether illnesses have been reported. No illnesses or injuries are documented in the source.
Plain-English summary
Sagent Pharmaceuticals is recalling Docetaxel Injection, USP (80 mg per 8 mL) due to the presence of particulate matter from the vial stopper. The affected lot is F1040001 (expiration date 12/31/2024), comprising 762 vials that were distributed nationwide.
Docetaxel is a chemotherapy drug administered by intravenous injection. Patients who received doses from this lot should inform their healthcare provider of the recall.
Healthcare facilities with inventory from lot F1040001 should stop dispensing and contact the FDA for guidance on returning the product.
The recalled product
- Product
- DOCETAXEL (DOCETAXEL ANHYDROUS)
- Brand
- DOCETAXEL
- Manufacturer
- Sagent Pharmaceuticals
- Category
- Drug — Injectable / Chemotherapy
- Hazard
- particulate-matter
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: F1040001
- Exp. Date 12/31/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DOCETAXEL
- CriticalDocetaxel Injection Recalled Nationwide for Stopper Particulate Matter
FDA (Drugs) · 2024-06-19
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27